Stay updated with breaking news from Strides Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On Thursday, 2241 stocks advanced, 1436 declined and 130 remained unchanged on the Bombay Stock Exchange (BSE), with an advance decline ratio of 1.56 indicating a positive closing of stocks in broader markets.
A long build-up was seen in 83 stocks including Balrampur Chini Mills, National Aluminium Company, Delta Corp, Hindustan Copper and Coforge.
The approval granted by the US Food & Drug Administration (USFDA) is for Mycophenolate Mofetil for oral suspension of strength 200 mg/ml, Strides Pharma Science said in a regulatory filing.
Global Ethosuximide Market Analysis (2019 - 2030)
Sharekhan recommended Hold rating on Strides Pharma Sciences with a target price of Rs 491 in its research report dated August 02, 2023.